180 related articles for article (PubMed ID: 15456475)
1. Recombinant factor VIIa: a general hemostatic agent? Yes.
Roberts HR
J Thromb Haemost; 2004 Oct; 2(10):1691-4. PubMed ID: 15456475
[No Abstract] [Full Text] [Related]
2. Recombinant factor VIIa: a general hemostatic agent? Not yet.
Levi M
J Thromb Haemost; 2004 Oct; 2(10):1695-7. PubMed ID: 15456476
[No Abstract] [Full Text] [Related]
3. Recombinant factor VIIa (eptacog alfa): a review of its use in congenital hemophilia with inhibitors, acquired hemophilia, and other congenital bleeding disorders.
Croom KF; McCormack PL
BioDrugs; 2008; 22(2):121-36. PubMed ID: 18345709
[TBL] [Abstract][Full Text] [Related]
4. Recombinant factor VIIa: a review on its clinical use.
Franchini M
Int J Hematol; 2006 Feb; 83(2):126-38. PubMed ID: 16513530
[TBL] [Abstract][Full Text] [Related]
5. Activated recombinant human coagulation factor VII (rFVIIa) therapy for abdominal bleeding in patients with inhibitory antibodies to factor VIII.
Liebman HA; Chediak J; Fink KI; Galvez AG; Shah PC; Sham RL
Am J Hematol; 2000 Mar; 63(3):109-13. PubMed ID: 10679799
[TBL] [Abstract][Full Text] [Related]
6. Recombinant-activated coagulation factor VIIa (NovoSeven): current development.
Weiskopf RB
Vox Sang; 2007 May; 92(4):281-8. PubMed ID: 17456151
[TBL] [Abstract][Full Text] [Related]
7. Potential role of recombinant factor VIIa as a hemostatic agent.
Hedner U; Erhardtsen E
Clin Adv Hematol Oncol; 2003 Feb; 1(2):112-9. PubMed ID: 16224390
[TBL] [Abstract][Full Text] [Related]
8. Recombinant factor VIIa, its clinical properties, and the tissue factor pathway of coagulation.
Bosinski TJ; El Solh AA
Mini Rev Med Chem; 2006 Oct; 6(10):1111-7. PubMed ID: 17073711
[TBL] [Abstract][Full Text] [Related]
9. NovoSeven for non-hemophilia hemostasis.
Med Lett Drugs Ther; 2004 Apr; 46(1181):33-4. PubMed ID: 15114252
[No Abstract] [Full Text] [Related]
10. Challenges in the therapeutic use of a "so-called" universal hemostatic agent: recombinant factor VIIa.
Hoots WK
Hematology Am Soc Hematol Educ Program; 2006; ():426-31. PubMed ID: 17124094
[TBL] [Abstract][Full Text] [Related]
11. Promising coagulation factor VIII bypassing strategies for patients with haemophilia A.
Duan X; Tang M; Zhang J; Yu H; Xu R
Blood Coagul Fibrinolysis; 2014 Sep; 25(6):539-52. PubMed ID: 24614429
[TBL] [Abstract][Full Text] [Related]
12. The concept of recombinant factor VIIa megadose for treating bleeding episodes in high-titer inhibitor patients with hemophilia: toward an expanding indication?
Negrier C
J Thromb Haemost; 2003 Mar; 1(3):423-4. PubMed ID: 12871444
[No Abstract] [Full Text] [Related]
13. Proceedings of the 6th Novo Nordisk Symposium on Treatment of Bleeding and Thrombotic Disorders. Copenhagen, Denmark, May 3-4, 2001.
Semin Hematol; 2001 Oct; 38(4 Suppl 12):1-50. PubMed ID: 11840984
[No Abstract] [Full Text] [Related]
14. Antidotes to haemorrhage: recombinant factor VIIa.
Kessler CM
Best Pract Res Clin Haematol; 2004 Mar; 17(1):183-97. PubMed ID: 15171966
[TBL] [Abstract][Full Text] [Related]
15. Factor VII deficiency and its treatment in delivery with recombinant factor VII.
Pehlivanov B; Milchev N; Kroumov G
Eur J Obstet Gynecol Reprod Biol; 2004 Oct; 116(2):237-8. PubMed ID: 15358473
[TBL] [Abstract][Full Text] [Related]
16. Recombinant coagulation factor VIIa: from the concept to clinical application in hemophilia treatment in 2000.
Hedner U
Semin Thromb Hemost; 2000; 26(4):363-6. PubMed ID: 11092209
[TBL] [Abstract][Full Text] [Related]
17. Recombinant FVIIa.
Hedner U
Vox Sang; 2004 Jul; 87 Suppl 2():25-8. PubMed ID: 15209873
[No Abstract] [Full Text] [Related]
18. Health economic review of recombinant activated factor VII for treatment of bleeding episodes in hemophilia patients with inhibitors.
Stephens JM; Joshi AV; Sumner M; Botteman MF
Expert Opin Pharmacother; 2007 Jun; 8(8):1127-36. PubMed ID: 17516876
[TBL] [Abstract][Full Text] [Related]
19. The use of rFVIIa in non-haemophilia bleeding conditions in paediatrics. A systematic review.
Mathew P
Thromb Haemost; 2004 Oct; 92(4):738-46. PubMed ID: 15467904
[TBL] [Abstract][Full Text] [Related]
20. Hemostatic effect of recombinant factor VIIa, NN1731 and recombinant factor VIII on needle-induced joint bleeding in hemophilia A mice.
Ovlisen K; Kristensen AT; Valentino LA; Hakobyan N; Ingerslev J; Tranholm M
J Thromb Haemost; 2008 Jun; 6(6):969-75. PubMed ID: 18363814
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
